Please ensure Javascript is enabled for purposes of website accessibility

Can Reynolds American Get a Reduced-Risk Label for This Tobacco Product?

By Rich Duprey - Jan 6, 2018 at 10:32AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It is the leading producer by far of this snuff-like product with a storied history.

The reduced-risk application Philip Morris International (PM -5.35%) filed for its iQOS heat-not-burn electronic cigarette seemingly gets the most media attention, but it is not the only company with such a petition before the U.S. Food and Drug Administration, nor was it the first. That distinction belongs to a Swedish manufacturer of a snuff-like offshoot called snus, and now the regulatory agency has agreed to accept another application for this little-known but increasingly popular tobacco product, this time from British American Tobacco's (NYSE: BTI) Reynolds American division.

A pinch between the cheek and gum

Snus are typically small packets of moist snuff that are placed under the upper lip, though tins of loose powder can also be found. The biggest manufacturer of snus in the U.S. is Reynolds, whose Camel brand is the leading moist snuff on the market. Swedish Match (SWMAF -2.02%) is the largest producer in Sweden, but the third largest in the U.S.

Variety of snus from Swedish Match

Image source: Swedish Match.

The history of snus extends back to the indigenous Taino people of the Caribbean, who first snorted ground-up seeds of a Mimosa-like tree that produced a hallucinogenic effect. This snuff-like powder called cohoba was first chronicled in 1497 by the monk Ramon Pane, who sailed with Christopher Columbus on his second journey to the Americas.

It ultimately was introduced into Europe, where it became associated with tobacco snuff. A Swedish customs document from the mid-1600s made the first official mention of snus, and in modern times it has grown so popular there that it has long since surpassed cigarettes in sales. Today, the sale of snus is banned in the European Union except for Sweden, as well as in Australia.

The market leader

In its third-quarter earnings report before officially folding into British American Tobacco's portfolio, Reynolds said Camel snus owned a rather staggering 75% share of the U.S. market. In comparison, its Camel brand of cigarettes had only an 8.3% share.

In March, Reynolds submitted 18 modified-risk applications with the FDA that cover six different styles of Camel snus. Recently, the agency accepted and filed them for substantive review, which should be completed within the year.

Reynolds notes in the SEC filing that the FDA has not granted any other manufacturer a reduced-risk designation, but that doesn't mean it wouldn't.

The potential for greater growth

Shortly after Philip Morris had submitted its IQOS reduced-risk application with the FDA in December 2016, the agency considered Swedish Match's application for its snus and ruled the company couldn't remove a warning label saying the products may cause gum disease and tooth loss, because the FDA found that they could.

However, the FDA held off on deciding whether the company could claim they were less harmful than cigarettes and whether they caused mouth cancer because it believed Swedish Match could refile an application "supporting issuance of modified risk orders."

Swedish Match may have overreached in its efforts to get a more favorable review than was warranted, but the FDA actually concluded snus "may pose substantially lower health risks to individual smokers who switch completely to these products." That bodes well for Reynolds when its snus come under review -- it could successfully become one of the first companies to earn a reduced-risk designation for a tobacco product.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

British American Tobacco p.l.c. Stock Quote
British American Tobacco p.l.c.
BTI
$42.85 (0.42%) $0.18
Philip Morris International Inc. Stock Quote
Philip Morris International Inc.
PM
$100.50 (-5.35%) $-5.68
Swedish Match AB (publ) Stock Quote
Swedish Match AB (publ)
SWMAF
$10.17 (-2.02%) $0.21

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
327%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.